4.6 Article

Early Assessment of Neoadjuvant Chemotherapy Response Using Multiparametric Magnetic Resonance Imaging in Luminal B-like Subtype of Breast Cancer Patients: A Single-Center Prospective Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

Christina Yau et al.

Summary: This study analyzed data from multiple independent cohorts to evaluate the relationship between residual cancer burden (RCB) and long-term prognosis in different subtypes of breast cancer. The results showed that higher RCB score was significantly associated with worse event-free survival in all breast cancer subtypes. The study suggests considering the evaluation of RCB as part of standard pathology reporting.

LANCET ONCOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy

M. Matsuda et al.

Summary: Synthetic MRI was used to predict pathological complete response in breast cancers after neoadjuvant chemotherapy, with SD of Pre-T2 being a significant and independent predictor of pCR. The results suggest potential for clinical application pending further verification.

CLINICAL RADIOLOGY (2022)

Article Oncology

Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore

Enora Laas et al.

Summary: The study compared the prognostic performance of Residual Cancer Burden (RCB) and Neo-Bioscore in different subtypes of breast cancer, finding that RCB had better prognostic performance in various subtypes. In the global population, both RCB and Neo-Bioscore were associated with disease-free and overall survival, but RCB had lower concordance index values.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Breast MRI for Evaluation of Response to Neoadjuvant Therapy

Beatriu Reig et al.

Summary: Neoadjuvant therapy is increasingly used for various types of breast cancer to shrink tumors, test treatment response, and provide prognostic information. MRI is the most accurate modality to show treatment response, but may overestimate or underestimate residual disease.

RADIOGRAPHICS (2021)

Article Health Care Sciences & Services

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI

Daniele La Forgia et al.

Summary: This study found that the BPE parameter could serve as a predictive marker for therapy response during neoadjuvant therapy in breast cancer patients. The variability of BPE during therapy was associated with treatment effectiveness, which could help improve decision-making in personalized medicine. Further investigations in conjunction with radiomics are warranted to validate these preliminary results.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Oncology

Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis

Filippo Pesapane et al.

Summary: The study aimed to predict the response to neoadjuvant chemotherapy in breast cancer patients using radiomic features extracted from MRI, in addition to biological characteristics. The combination of radiomics and clinical/biological models slightly improved the prediction of pathological complete responses, potentially helping to avoid unnecessary treatment.

CANCERS (2021)

Article Oncology

Neo-Adjuvant Chemotherapy in Luminal, Node Positive Breast Cancer: Characteristics, Treatment and Ontological Outcomes: A Single Center's Experience

Erika Barbieri et al.

Summary: The study found that luminal-like, node positive breast cancer patients have low pCR rates after NAC. Pre-operative chemotherapy increases the rate of breast-conserving surgery, and pCR emerged as an independent predictive factor for BCS.

EUROPEAN JOURNAL OF BREAST HEALTH (2021)

Article Oncology

Overview of radiomics in breast cancer diagnosis and prognostication

Alberto Stefano Tagliafico et al.

BREAST (2020)

Review Chemistry, Medicinal

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Huan Wang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Review Oncology

The Application of Radiomics in Breast MRI: A Review

Dong-Man Ye et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review

R. W. Y. Granzier et al.

EUROPEAN JOURNAL OF RADIOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer

Yunju Kim et al.

KOREAN JOURNAL OF RADIOLOGY (2018)

Article Medicine, General & Internal

Correlation of MRI features and pathohistological prognostic factors in invasive ductal breast carcinoma

Ana Marija Alduk et al.

ACTA CLINICA BELGICA (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Breast MRI: EUSOBI recommendations for women's information

Ritse M. Mann et al.

EUROPEAN RADIOLOGY (2015)

Review Oncology

Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy

Michael L. Marinovich et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Oncology

Neoadjuvant treatment of breast cancer

A. M. Thompson et al.

ANNALS OF ONCOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results

Claudette E. Loo et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2008)

Article Oncology

Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy

W. Fraser Symmans et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Review Surgery

Neoadjuvant chemotherapy for operable breast cancer

J. S. D. Mieog et al.

BRITISH JOURNAL OF SURGERY (2007)

Article Oncology

Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis

D Mauri et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

Classification of hypervascularized lesions in CE MR imaging of the breast

F Baum et al.

EUROPEAN RADIOLOGY (2002)

Article Multidisciplinary Sciences

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

T Sorlie et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Molecular portraits of human breast tumours

CM Perou et al.

NATURE (2000)